Ranitidine improves lymphocyte function after severe head injury: Results of a randomized, double-blind study

Critical Care Medicine

Volumn 24, Issue 11, 1996, Pages 1787-1792

  Rixen, Dieter ^a   Livingston, David H ^a,b   Loder, Patricia ^a   Denny, Thomas N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

B cell; critical illness; gastrointestinal hemorrhage; head injury; histamine; immunology; interferon ; lymphocyte; ranitidine; T cell; trauma

Indexed keywords

GAMMA INTERFERON; RANITIDINE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEAD INJURY; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STRESS; T LYMPHOCYTE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CRANIOCEREBRAL TRAUMA; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLASGOW COMA SCALE; HISTAMINE H2 ANTAGONISTS; HUMANS; INFUSIONS, INTRAVENOUS; INJURY SEVERITY SCORE; INTERFERON TYPE II; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANITIDINE;

EID: 0029843427     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199611000-00005     Document Type: Article

References (38)

1. Subramanian N, Bray MA: Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 1987; 138:271-275
2. Lima M, Rocklin RE: Histamine modulates in vitro IgG production by pokeweed mitogen-stimulated human mononuclear cells. Cell Immunol 1981; 64: 324-336
3. Dohlsten M, Sjögren HO, Carlsson R: Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production. Cell Immunol 1987; 109:65-74
4. Rocklin RE, Breard J, Gupta S, et al: Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF). Cell Immunol 1980; 51:226-237
5. Dohlsten M, Kalland T, Sjögren H-O, et al: Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand J Immunol 1988; 27: 527-532
6. 2-receptors. J Exp Med 1991; 74:281-284
7. Rocklin RE, Kiselis I, Beer DJ, et al: Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF). Cell Immunol 1983; 77:92-98
8. Osband ME, Shen Y-J, Shlesinger M, et al: Successful tumour immunotherapy with cimetidine in mice. Lancet 1981; i:636-638
9. Friedman H, Lee I, Waltz DT: Effects of histamine receptor antagonists metiamide and cimetidine on antibody formation in vitro by murine cells. Proc Soc Exp Biol Med 1982; 169:222-225
10. Descotes J, Tedone R, Evreux JC: Effects of cimetidine and ranitidine on delayed-type hypersensitivity. Immunopharmacology 1983; 6:31-35
11. Robertson AJ, Peden NR, Saunders JHB, et al: Cimetidine and the immune response. Lancet 1979; ii:420-421
12. Gifford RRM, Hatfield SM, Schmidtke JR: Cimetidine-induced augmentation of human lymphocyte blastogenesis by mitogen, bacterial antigen, and alloantigen. Transplantation 1980; 29:143-148
13. Peden NR, Robertson AJ, Boyd EJS, et al: Mitogen stimulation of peripheral blood lymphocytes of duodenal ulcer patients during treatment with cimetidine or ranitidine. Gut 1982; 23:398-403
14. Osband M, Gallison D, Miller B, et al: Concanavalin A activation of suppressor cells is mediated by the release of histamine and is blocked by cimetidine. Abstr. Clin Res 1980; 28:356
15. Brockmeyer NH, Kreutzfelder E, Bluhm C, et al: Immunomodulation of cimetidine in healthy volunteers. Klin Wochenschr 1989; 4:26-30
16. Bury TB, Corhay JL, Radermecker MF: Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 1992; 47: 624-629
17. Neugebauer E, Rixen D, Lorenz W: Histamine in septic/endotoxic shock. In: Handbook of Mediators in Septic Shock. Neugebauer E, Holaday J (Eds). Boca Raton, FL, CRC Press, 1993, pp 51-126
18. Nielsen HJ, Hammer JH, Moesgaard F, et al: Ranitidine prevents postoperative transfusion-induced depression of delayed hypersensitivity. Surgery 1989; 105:711-717
19. Nielsen HJ, Moesgaard F, Kehlet H: Ranitidine for prevention of postoperative suppression in delayed hypersensitivity. Am J Surg 1989; 157:291-294
20. Nielsen HJ, Pedersen BK, Moesgaard F, Haahr PM, Kehlet H: Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity. Acta Chir Scand 1898; 155:377-382
21. Nielsen HJ, Witt K, Moesgaard F, et al: Ranitidine for improvement of delayed hypersensitivity response in patients with sepsis. Acta Chir Scand 1989; 155: 445-449
22. Nielsen HJ, Hammer JH, Moesgaard F, et al: Ranitidine improves postoperative suppression of antibody response to preoperative vaccination. Surgery 1992; 111:69-73
23. Bovo P, Vaona B, Angelini G, et al: Ranitidine and delayed hypersensitivity. Abstr. Ital J Gastroenterol 1981; 13:49
24. Teasdale G, Jennett B: Assessment of coma and impaired consciousness: A practical scale. Lancet 1974; ii:81-83
25. Metz CA, Livingston DH, Smith JS, et al: The Ranitidine Head Injury Study Group: Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: A prospective, multicenter, double-blind, randomized trial. Crit Care Med 1993; 21:1844-1849
26. Baker SP, O'Neill B, Haddon W, et al: The Injury Severity Score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14:187-196
27. Denny T, Yogev R, Gelman R, et al: Lymphocyte subsets in healthy children during the first 5 years of life. JAMA 1992; 267:1484-1488
28. Kirchner H, Kleinicke C, Digel W: A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods 1982; 48: 213-219
29. 1-antagonism in rat endotoxic shock. Shock 1994; 2:47-52
30. 1-antagonism has beneficial effects on cardiovascular and pulmonary functions in porcine hyperdynamic endotoxic shock. Abstr. Shock 1994; 1(Suppl):22
31. 2-receptor antagonists on delayed hypersensitivity. Lancet 1978; i:624-626
32. Jorizzo JL, Sams WM, Jegasothy BV, et al: Cimetidine as an immunomodulator: Chronic mucocutaneous candidiasis as a model. Ann Intern Med 1980; 92: 192-195
33. Talpaz M, Medina JE, Patt YZ, et al: The immune restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patients. Clin Immunol Immunopathol 1982; 24:155-160
34. White WB, Ballow M: Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. N Engl J Med 1985; 312:198-202
35. Brockmeyer NH, Kreutzfelder E, Merlins L, et al: Immunomodulatory properties of cimetidine in ARC patients. Clin Immunol Immunopathol 1988; 48: 50-60
36. Livingston DH, Appel SH, Wellhausen SR, et al: Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123:1309-1312
37. Polk HC, Cheadle WC, Livingston DH, et al: A randomized prospective clinical trial to determine the efficacy of interferon gamma in severely injured patients. Am J Surg 1992; 163:191-196
38. Livingston DH, Loder PA, Kramer SM, et al: Interferon gamma administration increases monocyte HLA-DR antigen expression but not endogenous interferon production. Arch Surg 1994; 129: 172-178